AI platform for cancer drug discovery
At a glance
- Founded: 2018
- HQ: Durham
- Sector: Biotech
- Stage: Series B
- Total raised: $45M
- Last round: Growth
- Team size: 1-19
- Affiliation: Duke
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Where the team studied
Filter the directory by schoolDuke University
- Marcel FrenkelAlumPh.D.Source
- Mark HallenAlumPh.D.Source
Each line was checked against a primary source. Founder education is recorded for part of the directory, so a name missing here is a gap in what has been checked, not a statement that they studied somewhere else. Tell me what is missing.
Listed roles
All Triangle rolesChecking listed roles…